INTRODUCTION
============

Platelet-derived growth factor (PDGF), which was originally isolated from human platelets, is composed of four polypeptide chains designated A, B, C and D. These polypeptide chains make up five biologically active dimeric PDGF isoforms: PDGF-AA, -AB, -BB, -CC and -DD, which exert their effects through two tyrosine kinase receptors, PDGFR-α and PDGFR-β ([@B1; @B2; @B3]). PDGF-A and PDGF-B are considered to be major mitogens for a variety of mesenchymal cell types. They play critical roles in normal embryonic development, cellular differentiation and wound healing ([@B1; @B2; @B3; @B4]). The overactivity of the PDGFs has been implicated in the pathogenesis of a number of diseases characterized by excessive cell growth, including cancer, atherosclerosis and various fibrotic conditions ([@B3],[@B5],[@B6]). Significantly augmented expression of the PDGF-A gene has been observed in a number of human tumor cell lines and tissues, particularly in gliomas, sarcomas and ostoastrocytomas ([@B6; @B7; @B8; @B9; @B10]). Abnormal PDGF-A expression is linked to accelerated malignant cell growth through autocrine and paracrine pathways ([@B1],[@B6],[@B11]). For these reasons, PDGF signaling pathways are important targets for anticancer therapeutics; specifically, inhibitors of *PDGF-A* gene expression could be valuable in the treatment of some cancers.

Transcription of the PDGF-A gene is controlled by several positive and negative regulatory elements located in the promoter region and the 5′-distal upstream region of the gene ([Figure 1](#F1){ref-type="fig"}) ([@B12; @B13; @B14]). An important, highly guanine- and cytosine-rich region located at nucleotides --120 to --33 within the *PDGF-A* promoter accounts for 80% of basal promoter activity. This GC-rich region was originally identified by its sensitivity to the single-strand-specific endonuclease S1 nuclease and has been termed the nuclease hypersensitive element (NHE) ([@B12; @B13; @B14]). *PDGF-A* is also subject to transcriptional repression by two discrete S1 nuclease hypersensitive (SHS) elements. One is located within the 5′-distal region (--1418 to --1338) of the promoter (5′SHS), while the other is located within the first intron (+1605 to +1630, intron SHS) ([@B14; @B15; @B16; @B17]). Multiple transcription factors bind to and regulate *PDGF-A* genes through the NHE region, such as Sp1, Egr-1, Wilms' tumor protein (WT1), GC factor 2 (GCF2), nuclear factor 1-X (NF1-X) and the metastasis suppressor protein NM23 ([@B17; @B18; @B19; @B20; @B21; @B22; @B23]). This region is structurally dynamic and capable of adopting non-B-DNA conformations ([@B24]). The importance of the unwound paranemic structure of NHE in *PDGF-A* promoter activity was confirmed by demonstrating that a single-stranded DNA oligomer, derived from the guanine-rich strand (--74 to --51), inhibits the promoter activity of *PDGF-A* ([@B24]). It is believed that the equilibrium between the B-form DNA, the single-stranded DNA, and intramolecular secondary DNA structures is instrumental in the determination of the binding of transcription factors to the NHE region of PDGF-A (NHE~PDGF-A~). However, the molecular details of the unwinding of secondary structures in the NHE~PDGF-A~ are poorly understood. Figure 1.(**A**) Promoter structure of *PDGF-A* and locations of the important NHEs. The sequences of the 5′SHS, the G-rich strand of the NHE and the intron SHS are shown. TSS = transcriptional start site. (**B**) Structure of a G-tetrad and examples of the folding patterns of known intramolecular G-quadruplexes.

Tandem repeats of the guanine-tract (G-tract) sequence adopt specific intramolecular G-quadruplex structures in the telomeres and promoters of several important genes, such as *c-MYC*, *KRAS*, *Bcl-2*, c-Kit and *VEGF* ([@B25; @B26; @B27; @B28; @B29]). The basic building block, the G-tetrad, and examples of folding patterns are shown in [Figure 1](#F1){ref-type="fig"}B. The involvement of G-quadruplex structures in cellular processes, such as transcriptional control of *c-MYC* expression, has stimulated the development of anticancer drugs that are selective for G-quadruplexes. The G-rich strand of NHE~PDGF-A~ contains five contiguous guanine runs, each separated by one base. The G-tract motif in NHE~PDGF-A~ has some similarity to the G-tract motif in the NHE region of *c-MYC* (NHE~c-MYC~). However, in NHE~c-MYC~ the minimum number of guanines in any run is three rather than four, and NHE~PDGF-A~ contains a very long run of 13 contiguous guanines at the 5′-end (see sequences in [Figure 2](#F2){ref-type="fig"}A) ([@B25],[@B30]). Since the G-rich strand of NHE~c-MYC~ is known to form G-quadruplex structures, by analogy the G-rich strand of NHE~PDGF-A~ has the potential to form G-quadruplex structures under physiological conditions. Consequently, these G-quadruplex structures may play an important role in modulating the expression of *PDGF-A*. For these reasons, this work examines the *in vitro* formation and properties of G-quadruplex structures within the G-rich strand of NHE~PDGF-A~, including its transcriptional modulation by TMPyP4. Figure 2.(**A**) Comparative CD spectra of three known G-quadruplex-forming sequences with the PDGF-A Pu48-mer. Blue line = PDGF-A Pu48-mer (25 mM KCl), red line = c-Myc Pu27-mer (parallel G-quadruplex in 25 mM KCl), green line = Bcl-2 Pu39WT (mixed parallel/antiparallel G-quadruplex in 100 mM KCl), black line = TBA (antiparallel G-quadruplex in 100 mM KCl). All CD data were obtained with a 5 μM strand concentration at 25°C. Comparison of sequences of these two DNA oligomers is shown under the CD spectra. (**B**) Native gel electrophoresis indicating the formation of intramolecular G-quadruplex structures by Pu48-mer. The fast mobility major band represents the intramolecular G-quadruplex and the slow mobility bands represent the higher-order intermolecular G-quadruplexes. (**C**) Effect of alkali metals on the Pu48-mer CD spectra. Effect of KCl (red line) and NaCl (blue line) on the ellipticity signal compared to the signal in the absence of salt (black line). All CD data were obtained with a 5 μM strand concentration at 25°C.

MATERIALS AND METHODS
=====================

Oligodeoxynucleotides, enzymes, materials and drugs
---------------------------------------------------

DNA oligomers (sequences shown in [Table 1](#T1){ref-type="table"}) were obtained from Sigma Genosys and Biosearch Technologies, Inc. All DNA oligomers were PAGE-purified and dissolved in double-distilled water before use. The extinction coefficients that the manufacturers provided for a given DNA sequence were calculated using the nearest-neighbor method ([@B31]). When the DNA oligomers fold into a G-quadruplex, the base stacking results in hyperchromicity. Thus, the extinction coefficients of DNA oligomers that can form DNA secondary structures need to be corrected for the hyperchromicity. To address this issue, we used UV/vis thermal denaturation techniques to determine the high-order structural hyperchromicity of the G-quadruplex-forming DNA oligomers ([@B32]). The UV experiments were carried out on a Cary 300 Bio UV-visible spectrophotometer. Cells with optical path lengths of 10 mm were used, and the temperature of the cell holder was controlled by an external circulating water bath (Varian). The UV melting experiments were done by collecting spectra every five degrees as the sample heated up from 20 to 100°C, and monitoring the absorption change at λ~max~. The plateau at the top of the melting curve (usually 20°C above the respective *T*~m~) was extrapolated back to 20°C to obtain the hyperchromicity. The extinction coefficient for the G-quadruplex-forming DNA oligomer was corrected by using the following equation: ~260~(Q) = ~260~(N)/(1 + (%hyperchromicity/100)). ~260~(Q) represents the extinction coefficient for the G-quadruplex-forming DNA oligomer, and ~260~(N) represents the extinction coefficient for the non-structured single-stranded DNA oligomers. The corrected ~260~(Q) values for select DNA oligomers in our study are as follows: PDGF-A Pu48, 533680 M^−1^ cm^−1^; PDGF-A Pu60, 672353 M^−1^ cm^−1^; PDGF-A Pu90, 1000303 M^−1^ cm^−1^; PA-5W, 379701 M^−1^ cm^−1^; PA-Mut1, 360524 M^−1^ cm^−1^; PA-Mut2, 369612 M^−1^ cm^−1^; c-MYC Pu27, 354938 M^−1^ cm^−1^; TBA, 151770 M^−1^ cm^−1^ and Bcl-2 Pu38WT, 453766 M^−1^ cm^−1^. Acrylamide:bisacrylamide (29:1) solution and ammonium persulfate were purchased from Bio-Rad, and *N*,*N*,*N*′,*N*′-tetramethylethylenediamine was purchased from Fisher. T4 polynucleotide kinase and *Taq* DNA polymerase were purchased from Promega. \[γ-^32^P\]ATP was purchased from NEN Dupont. TMPyP2, TMPyP4 and Se2SAP were synthesized in our laboratory. Telomestatin was kindly provided by Dr Kazuo Shin-ya (University of Tokyo, Japan). Stock solutions of telomestatin and Se2SAP (10 mM) were made using DMSO (10%) and double-distilled water, respectively. Further dilutions to working concentrations were made with double-distilled water immediately prior to use. Plasmid pGL3-basic, pRL-TK and dual luciferase assay kits were purchased from Promega. Table 1.Oligodeoxynucleotides used in this studyDNA oligomerSequence (5′ → 3′)PDGF-A Pu48GGAGGC **GGGGG GGGGG GGG**C**G GGGG**C **GGGGG** C**GGGG** GAGGG GCGCG GCPDGF-A Pu60CCGGG GAGGC **GGGGG GGGGG GGG**C**G GGGG**C **GGGGG** C**GGGG G**A**GGG G**CGCG GCGGC GGCGGPDGF-A Py60CCGCC GCCGC CGCGC CCCTC CCCCG CCCCC GCCCC CGCCC CCCCC CCCCC GCCTC CCCGGPDGF-A Pu90TGCGG GTCCC AGGCC CGGAA TCCGG GGAGG C**GGGG GGGGG GGGG**C **GGGGG** C**GGGG G**C**GGG GG**A**GG GG**CGC GGCGG CGGCG GCTAT AACCCTemplate[^a^](#TF1){ref-type="table-fn"}CGGG GAGGC **GGGGG GGGGG GGG**C**G GGGG**C **GGGGG** C**GGGG G**A**GGG G**CGCG GTTAG TCAGA CCTCG ACGCA TTTGC TTAGA GTCGAPrimer[^b^](#TF2){ref-type="table-fn"}TCGAC TCTAA GCAAA TGCGT CGAGc-MYC Pu27T**GGGG** A**GGG**T **GGGG**A **GGG**T **GGGG** AAGGTBA**GG**TT **GG**TG T**GG**T T**GG**Bcl-2 Pu39WTA**GGGG** C**GGG**C GC**GGG** A**GG**AA **GGGGG** C**GGG**A GC**GGGG** CTGPA-5WAGGC **GGGGG GGGGG GGG**C**G GGGG**C **GGGGG** C**GG**PA-Mut1AGGC **GGGGG GGGGG GGG**CT **GGGG**C T**GGGG** C**GG**PA-Mut2AGGC **GGGGG GGGGG GGG**CA **GGGG**C A**GGGG** C**GG**[^1][^2]

Circular dichroism spectroscopy
-------------------------------

CD spectra were recorded on a Jasco-810 spectropolarimeter (Easton, MD, USA) using a quartz cell of 1 mm optical path length and an instrument scanning speed of 100 nm/min, with a response time of 1 s, over a wavelength range of 200--330 nm. All DNA samples were dissolved and diluted in Tris--HCl buffer (50 mM, pH 7.6), and where appropriate, the samples also contained different concentrations of KCl and/or NaCl. The DNA strand concentrations were 5 μM, and the CD data represent four averaged scans taken at an experimental temperature (25--110°C). All CD spectra are baseline-corrected for signal contributions due to the buffer.

Labeling and purification of oligodeoxyribonucleotides
------------------------------------------------------

The DNA oligomers were 5′-end-labeled with \[γ-^32^P\]ATP using T4 polynucleotide kinase for 1 h at 37°C. The labeling reaction was inactivated by heating the samples at 90°C for 8 min after the addition of 1.5 μl of 0.5 M EDTA. The 5′-end labeled DNA was then purified using a Bio-Spin 6 chromatography column (Bio-Rad). The labeled DNA was further purified by running a 12% denatured polyacrylamide gel that contained 8.0 M urea.

Preparation of intramolecular G-quadruplex structures by EMSA
-------------------------------------------------------------

The 5′-end ^32^P-labeled single-stranded DNA oligomer was incubated in Tris--HCl buffer (50 mM, pH 7.6) containing different concentrations of KCl and/or NaCl for 1 h at room temperature. The denatured marker DNA oligomers were prepared separately before the EMSA. The control DNA oligomers were heated at 95°C for 15 min. They were then immediately put on ice and cooled to 4°C before loading the gel. The secondary structures of the DNA oligomers were obtained by heating the stock solutions at 90°C for 10 min and then slowly cooling to room temperature over 4 h. The monomolecular G-quadruplex structure of the G-rich strand of the NHE was isolated by non-denatured gel electrophoresis in the presence of 10 mM NaCl and KCl in Tris-Borate-EDTA buffer. Electrophoresis of the DNA was conducted at 150 V. The different mobility shift DNA bands were cut from the non-denatured gel and soaked in double-distilled water. The double-stranded 60-mer NHE was obtained first by annealing equal amounts of 60-mer G-rich strand (Pu60-mer, 5′-end ^32^P-labeled) and C-rich strand (Py60-mer) in annealing buffer (10 mM Tris--HCl, pH 7.5, 10 mM NaCl), heating the mixtures at 75°C for 15 min, and then slowly cooling the DNA sample to room temperature. The major double-stranded DNA band was isolated from a 12% native polyacrylamide gel. For inducing the formation of G-quadruplexes in the duplex DNA, the double-stranded 60-mer NHE was incubated in different concentrations of KCl buffers at room temperature for at least 1 h, then heated at 65°C and allowed to slowly cool to room temperature over 4 h.

*Taq* polymerase stop assay
---------------------------

The DNA primer 5′-d(TCGACTCTAAGCAAATGCGTCGAG)-3′ was 5′-end-labeled with ^32^P as described above. The labeled primer was annealed to the DNA template (sequence shown in [Table 1](#T1){ref-type="table"}) by using the aforementioned protocol. The DNA complex formed by annealing the primer to the template was purified using gel electrophoresis on a 12% native polyacrylamide gel. The purified DNA was then diluted to a concentration of 0.2 nM and mixed with the reaction buffer (10 mM MgCl~2~, 0.5 mM DTT, 0.1 mM EDTA, 1.5 μg/μl BSA) and 0.1 mM dNTPs. Where appropriate, KCl, NaCl and/or drugs were also added. The reaction mixtures were incubated for 1 h at room temperature, allowing the alkali metal ions or drugs to stabilize the G-quadruplexes. *Taq* DNA polymerase was then added, and samples were incubated for 30 min at 60°C for polymerase extension. The polymerase extension reaction was stopped by adding 2× stop buffer (10 mM EDTA, 10 mM NaOH, 0.1% xylene cyanole, 0.1% bromophenol blue in formamide solution), and the samples were analyzed on a 16% denatured polyacrylamide gel ([@B33]).

DMS footprinting
----------------

Each band of interest was excised from the EMSA and soaked in 1× Tris-Borate-EDTA buffer containing 10 mM NaCl and KCl. The samples were then vigorously agitated at room temperature for 3 h in water. The solutions were filtered and 50 000 c.p.m. per reaction of DNA solution was further diluted with 0.1× TE (10 mM Tris, 1 mM EDTA, pH 7.5) to a total volume of 90 μl per reaction. Following the addition of 1 μl calf thymus DNA (0.1 μg/μl), the reaction mixture was incubated with 1 μl of 25% dimethyl sulfate solution (DMS:ethanol; 1:4, vol/vol) for 5 or 10 min. Each reaction was stopped by adding 18 μl of stop buffer (3 M β-mercaptoethanol:water:NaOAc; 1:6:7, vol/vol). After ethanol precipitation and washing, the piperidine cleavage reaction was performed by heating the samples to 90°C for 30 min in 30 μl piperidine. The samples were separated on a 20% denatured polyacrylamide gel and visualized on a phosphorimager (Storm 820). DMS analysis of random unstructured control DNA oligomer was performed in the same way by using heat-denatured (quick cooling on ice) 5′-end-labeled oligomer ([@B25]).

Imaging and quantitation
------------------------

The dried gel was exposed on a phosphor screen. Imaging and quantitation were performed using a phosphorimager (Storm 820) and ImageQuant 5.1 software from Amersham Biosciences.

Plasmid construction
--------------------

The DNA sequence of the --222 to +119 region of the *PDGF-A* promoter, relative to the transcriptional start site ([@B12],[@B13]), was obtained by PCR-amplifying human genome DNA extracted from HPDE-6 cells with the primer pair (5′-GGGGCTTTGATGGATTTAGC-3′ and 5′-CCTGAGGGCGGCGCAAGGCCG-3′). This fragment was subcloned into the multiple cloning sites region, between HindIII and *ScaI*, of the pGL3-basic vector (Promega), which is a promoter-less plasmid containing the firefly luciferase reporter gene. The resultant clone pA361 was characterized by DNA sequencing, and the correct orientation of the insert was verified by restriction enzyme analysis.

Cell culture, transient transfection and dual luciferase assay
--------------------------------------------------------------

Human pancreatic cancer MIA PaCa-2 cells were cultured in Dulbecco\'s Modified Eagle\'s Medium, containing 100 U/ml penicillin, 100 μg/ml streptomycin, 200 mM [L]{.smallcaps}-glutamine and 10% FBS (Mediated Inc.). Cells were maintained in a logarithmic phase of growth. For transfection experiments, cells were seeded in 6-well dishes with a concentration of 2 × 10^5^ cells per well and treated with varying concentrations of TMPyP4 or TMPyP2 (up to 50 μM). Each well was co-transfected with 2 μg of pA361 and 25 ng of pRL-TK with TransFectin (BioRad). pRL-TK (Promega), containing a renilla luciferase gene driven by the herpes simplex virus thymidine kinase promoter, was used as a control for transfection efficiency. The expression of firefly luciferase, with respect to that of renilla luciferase, was determined by dual luciferase assay (Promega), 24 h after transfection (as described by the manufacturer). Cell lysate (20 μl) was mixed with 100 μl of reconstituted luciferase assay reagent, and light output was measured for 12 s with a FB12 Luminometer (Berthold).

RESULTS
=======

The G-rich strand of the *PDGF-A* NHE forms intramolecular G-quadruplex structures
----------------------------------------------------------------------------------

Since signature CD spectra have been determined for several well-defined G-quadruplex structures in solution, comparative CD analysis can provide primary evidence for the existence of G-quadruplex structures in an unknown DNA sequence and also provide insight into the topology of G-quadruplexes ([@B34; @B35; @B36; @B37; @B38; @B39; @B40; @B41; @B42; @B43; @B44]). To determine the potential presence of G-quadruplex structures within the G-rich strand of NHE~PDGF-A~, we used CD to analyze the purine strand Pu48-mer, which represents the whole core sequence of the G-rich strand of NHE~PDGF-A~ (--40 to --87 in the *PDGF-A* promoter). [Figure 2](#F2){ref-type="fig"}A (blue line) shows that Pu48-mer exhibited a CD spectrum characterized by a maximum positive ellipticity at 266 nm, a negative band at 240 nm and a minor positive band at 212 nm. This spectrum is similar to that of the guanine-rich DNA oligomer Pu27-mer of NHE~c-MYC~ (red line in [Figure 2](#F2){ref-type="fig"}A), which forms intramolecular parallel G-quadruplex structures that have been well characterized by NMR, CD and DMS footprinting studies ([@B29],[@B38],[@B45]). To further identify the topology of the G-quadruplex structures formed in Pu48-mer, we compared the CD spectrum of Pu48-mer to two other DNA sequences, the thrombin binding aptamer (TBA) (black line in [Figure 2](#F2){ref-type="fig"}A) and the *Bcl-2* Pu39WT (green line in [Figure 2](#F2){ref-type="fig"}A). The chair-type antiparallel G-quadruplex structure of TBA has been proposed on the basis of NMR and X-ray crystallography ([@B46]), and it has a signature CD spectrum characterized by a positive maximum band around 290 nm, a negative band at 265 nm and a smaller positive band at 246 nm. The hybrid parallel/antiparallel G-quadruplex structure of *Bcl-2* Pu39WT was solved by NMR ([@B47]). The CD spectrum of this hybrid G-quadruplex structure shows a major positive band at ∼ 265 nm with a negative band at 240 nm, which is similar to the parallel G-quadruplex. However, it has a unique pronounced shoulder absorption between 280 and 300 nm, which is not observed in the CD spectrum of the parallel G-quadruplex ([@B27]). The CD spectrum of the Pu48-mer is quite different from those of *Bcl-2* Pu39WT and TBA, and it resembles most closely that of the c-MYC Pu27-mer. Collectively, these data suggest that the major G-quadruplex structure in the Pu48-mer is a parallel structure.

DNA oligomers folding into intramolecular G-quadruplex structures migrate faster than non-structured single-stranded DNA and the corresponding intermolecular dimers in a native gel ([@B48],[@B49]). Thus, it is possible to isolate the intramolecular G-quadruplex structure from the other DNA structures by native gel electrophoresis. To determine whether the G-quadruplexes formed by Pu48-mer in our CD studies are intra- or intermolecular, we analyzed the electrophoretic mobilities of different concentrations of Pu48-mer in the presence of 50 mM KCl. When the DNA concentration was 15 μM or lower ([Figure 2](#F2){ref-type="fig"}B, lanes 2--4), the major DNA species of Pu48-mer migrated in an 8% native polyacrylamide gel much faster than the corresponding denatured Pu48-mer that represents the random linear DNA structure ([Figure 2](#F2){ref-type="fig"}B, lane 1 as control). These results suggest that the Pu48-mer folds into a compact intramolecular G-quadruplex at low DNA concentrations. However, when the DNA concentration was 20 μM, more than 40% of the Pu48-mer was found as a slowly migrating species, which is presumed to represent higher-order intermolecular DNA complexes ([Figure 2](#F2){ref-type="fig"}B, lane 5). Since the concentration of the DNA oligomer used in our CD studies is 5 μM, it is reasonable to assume that the G-quadruplexes formed in these conditions are intramolecular.

K^+^ facilitates the formation of intramolecular G-quadruplexes in the G-rich strand of NHE~PDGF-A~
---------------------------------------------------------------------------------------------------

To examine the effects of the alkali metal ions (K^+^ and Na^+^) on the formation of G-quadruplexes in the G-rich strand of NHE~PDGF-A~, we monitored the CD spectra of Pu48-mer in the presence of either 100 mM KCl or 100 mM NaCl. These CD spectra showed similar parallel G-quadruplex characteristics. However, a dramatic increase in the elliptic intensity was observed with the sample that was pre-incubated with 100 mM KCl ([Figure 3](#F3){ref-type="fig"}A, red line), while 100 mM NaCl only slightly increased the magnitude of the CD signal around 280--300 nm ([Figure 2](#F2){ref-type="fig"}C, blue line) as compared to the spectrum of DNA in the Tris--HCl buffer alone ([Figure 2](#F2){ref-type="fig"}C, black line). This indicates that K^+^ or Na^+^ can increase the formation of the *PDGF-A* Pu48-mer G-quadruplex, but a more significant effect occurs with K^+^. K^+^ strongly increases the formation of the parallel Pu48-mer G-quadruplex structure, while Na^+^ appears to induce the formation of a hybrid parallel/antiparallel Pu48-mer G-quadruplex structure. Further evidence that K^+^ stabilizes the Pu48-mer G-quadruplex structure was obtained by comparing the melting curve of Pu48-mer in the absence or presence of KCl. We monitored the CD spectra of Pu48-mer as a function of temperature and then plotted the ellipticity at 266 nm versus temperature to generate a melting curve. The full melting curve of Pu48-mer in Tris--HCl (50 mM, pH 7.2) showed a *T*~m~ of 75°C (data not shown). This high *T*~m~ suggests that intramolecular Pu48-mer G-quadruplex structures are very stable. Surprisingly, in the presence of 25 mM KCl, the Pu48-mer still showed a detectable parallel G-quadruplex CD signal at 110°C. Because of the high-temperature limit of our CD instrument, we could not obtain a full melting curve for the Pu48-mer in 25 mM KCl. This result implies that K^+^ can significantly stabilize the Pu48-mer G-quadruplex and increase its *T*~m~. Figure 3.Effect of K^+^ and Na^+^ on the formation of the NHE~PDGF-A~ G-quadruplex in a *Taq* polymerase stop assay. Two stop products are designated as the 5′-end product and the 3′-end stop product. The corresponding arrest sites are indicated on the core G-tract sequence.

The specific stabilizing effect of K^+^ on the formation of G-quadruplexes in the NHE~PDGF-A~ was confirmed by *Taq* polymerase stop assay. This assay is a useful tool to investigate the capability of G-rich DNA sequences to form stable G-quadruplex structures *in vitro*, based on the assumption that a stable DNA secondary structure in the DNA template is able to stop primer extension by the DNA polymerase ([@B33]). A cassette template DNA containing the Pu48-mer of NHE~PDGF-A~ was annealed with a labeled primer, which subsequently was extended with *Taq* polymerase in the presence of increasing concentrations of KCl or NaCl. A full-length product was synthesized in the presence of NaCl ([Figure 3](#F3){ref-type="fig"}, lanes 3--5); however, upon replacement of NaCl by KCl to the reaction, two major premature primer extension products were produced and designated as the 5′-end stop product and the 3′-end stop product ([Figure 3](#F3){ref-type="fig"}, lanes 7--9). Both of these arrest products increased in a K^+^-dependent manner but were not affected by Na^+^. Thus, the K^+^-specific block to DNA synthesis is not due to general effects of alkali ions. Collectively, these results suggest that the G-rich strand of NHE~PDGF-A~ has the capacity to form two separate intramolecular parallel G-quadruplex structures that are preferentially stabilized by K^+^.

Formation of multiple G-quadruplex structures in the G-rich strand of NHE~PDGF-A~
---------------------------------------------------------------------------------

The G-rich strand of NHE~PDGF-A~ is composed of five G-tracts and has the potential to form multiple G-quadruplexes structures, based on the assumption that each G-tract has an equal possibility of participating in the formation of G-quadruplexes. The *Taq* polymerase stop assay in [Figure 3](#F3){ref-type="fig"} showed that two significant stop products are formed within the NHE~PDGF-A~. This indicates that at least two major, stable intramolecular G-quadruplex structures are formed by different G-tracts in the G-rich strand of NHE~PDGF-A~. The *Taq* polymerase arrest sites for these two major stop products were determined by sequencing the template DNA. The arrested site for the 3′-end stop product corresponded to G41 in the *PDGF-A* Pu48-mer (core sequence of NHE~PDGF-A~, as shown under the gel in [Figure 3](#F3){ref-type="fig"}). The arrest product at G41 suggest that bases G37--G41 must form a stable cap structure on the 3′-end of the G-quadruplex. The arrested site for the 5′-end stop product corresponded to G25 in the Pu48-mer ([Figure 3](#F3){ref-type="fig"}). This indicates that the three consecutive runs of guanines at the 5′-end of Pu48-mer (G1--G25) form the G-quadruplex structure of the 5′-end stop product. One structural characteristic of particular interest is that the 13-mer G-tract must provide the two runs of presumably four guanines at the 5′-end of the G-quadruplex.

Native polyacrylamide gel electrophoresis of Pu48-mer, which was pre-incubated with 100 mM KCl, shows two fast migrating bands ([Figure 4](#F4){ref-type="fig"}A, bands 1 and 2) that move faster than the denatured unstructured linear DNA species (band 3). These high-mobility species are presumed to represent compact intramolecular G-quadruplex structures. The close mobility and broadness of two intramolecular G-quadruplexes (bands 1 and 2) indicate that the Pu48-mer may form multiple similarly structured intramolecular G-quadruplexes. Figure 4.The EMSA (**A**) and DMS footprinting (**B**) of intramolecular G-quadruplex structures of *PDGF-A* Pu48-mer. In (A), high-mobility bands 1 and 2 represent compact intramolecular G-quadruplex structures, and band 3 represents linear DNA, which was fully denatured by heating. In (B), DMS footprinting of band 1 (lanes 1 and 2), band 2 (lanes 4 and 5) and band 3 (lane 3) from (A) is shown. Open circles indicate the guanines that are fully protected, partially open circles indicate the guanines that are partially protected and arrowheads indicate the guanines that are cleaved.

To further probe the structures of the two intramolecular G-quadruplexes, a DMS footprinting experiment was carried out. Since N7 of guanine in a G-tetrad is involved in Hoogsteen bonding and is inaccessible to alkylation by DMS, we can identify those guanine bases engaged in the formation of a G-quadruplex structure. The DMS methylation pattern produced by band 3 was consistent with a linear single-stranded DNA ([Figure 4](#F4){ref-type="fig"}B, lane 3). For bands 1 and 2 ([Figure 4](#F4){ref-type="fig"}B, lanes 1 and 2 and lanes 3 and 4), the DMS protection patterns suggested the formation of intramolecular G-quadruplexes. As shown in [Figure 4](#F4){ref-type="fig"}B (lanes 1 and 2), full DMS protection occurred within the four runs of guanines (G3--G4, G8--G10, G16--G19 and G22--G25) of band 1. For band 1, the DMS protection of the two four-guanine G-tracts (G16--G19, G22--G25) at the 3′-end of the NHE~PDGF-A~ is clear, while the remaining two G-tracts within the run of 13 guanines at the 5′-end of the NHE~PDGF-A~ are less well defined. Within the long run of 13 guanines there are two runs of guanines that are clearly protected: a run of two guanines (G3--G4) and three guanines (G8--G10). Partial protection of the intervening run of guanines (G5 and G7) occurs between these two fully protected regions, and likewise G11 is partially protected. The first guanine involved in the formation of the G-tetrad at the 3′-end of band 1 is G25. This corresponds to the arrest site for the 5′-end stop product in the *Taq* polymerase stop assay ([Figure 3](#F3){ref-type="fig"}). For band 2 (lanes 4 and 5), most guanines within the two 5′-runs of guanine (G1--G13 and G15--G19), with the exception of G1 and G2, were partially protected from DMS methylation, with only two runs of guanines (G22--G25 and G27--G30) showed full protection ([Figure 4](#F4){ref-type="fig"}B, lanes 4 and 5). These somewhat ill-defined N7 methylation protection patterns do not provide straightforward insight into the specific G-quadruplex structures for the DNA species in bands 1 and 2. Most probably these ill-defined bands result from mixtures of multiple intramolecular G-quadruplexes existing in dynamic equilibrium (see Discussion Section).

### Formation of a G-quadruplex within the double-stranded DNA of NHE~PDGF-A~

To date, all well-characterized G-quadruplex structures have been determined by studying single-stranded DNA *in vitro* ([@B25; @B26; @B27; @B28; @B29; @B30],[@B35],[@B36],[@B41],[@B42]). To investigate the potential for G-quadruplex formation within the duplex DNA of NHE~PDGF-A~, we used CD to study a 90 base pair duplex DNA, derived from the --24 to --113 region of the PDGF-A promoter, that contained about 20 base pairs flanking each side of the NHE core sequence. Significantly, the CD spectrum of the NHE 90 bp double-stranded DNA exhibited an almost identical CD spectrum to the parallel G-quadruplex formed in the single-stranded DNA ([Figure 2](#F2){ref-type="fig"}A, blue line), which is characterized by a positive ellipticity maximum at 266 nm and a negative minimum at 240 nm ([Figure 5](#F5){ref-type="fig"}A). This CD spectrum is substantially different from the CD signal of B-form duplex DNA, which typically has an ellipticity maximum absorption around 275--280 nm and zero ellipticity at 258 nm. In addition, the CD bands of B-form DNA are much weaker ([@B34],[@B50],[@B51]). This CD profile of the NHE 90 bp double-stranded DNA indicates that a dominant intramolecular parallel G-quadruplex is formed within the duplex DNA of NHE~PDGF-A~. To determine the stability of this G-quadruplex structure, we monitored the CD spectra of the NHE 90 bp double-stranded DNA over a 25--100°C temperature range. Notably, the DNA sample still generated very strong parallel G-quadruplex CD signals, even above 100°C ([Figure 5](#F5){ref-type="fig"}A). This indicates that the G-quadruplex structure formed in the NHE duplex DNA is very stable. Figure 5.(**A**) Effect of temperature (25--100°C) on the CD spectra of 90 bp duplex DNA containing NHE~PDGF-A~. At 100°C, 90 bp duplex DNA of NHE~PDGF-A~ still generated a strong G-quadruplex CD signal. (**B**) Non-denatured gel analysis of 60-mer G-rich single-stranded DNA of NHE~PDGF-A~ (lane 1) and 60 bp double-stranded DNA of NHE~PDGF-A~ (lanes 2 and 3). In lanes 1 and 2, the G-rich strand was 5′-end-radiolabeled with ^32^P, and the C-rich strand was 5′-end-radiolabeled with ^32^P in lane 3. (**C**) DMS footprinting for G-rich strands of 60 bp duplex DNA band 1 (lanes 1 and 2) and band 2 (lanes 3 and 4). Lane 5 shows the CT sequencing on the G-rich strand of the 60 bp duplex DNA of NHE~PDGF-A~. Open circles indicate the guanines that are fully protected, partially open circles indicate the guanines that are partially protected, and arrowheads indicate the guanines that are cleaved.

To identify the G-quadruplex structure formed in the NHE duplex DNA, a 60 bp double-stranded DNA of NHE (--33 to --92 in the PDGF-A promoter), which was shown to have better resolution for DMS footprinting than the 90 bp double-stranded DNA, was used. The CD spectrum of purified NHE 60-mer double-stranded DNA was consistent with that of the NHE 90 bp double-stranded DNA (data not shown). EMSA was performed to isolate the duplex DNA species containing the G-quadruplex structure, which was 5′-end ^32^P-labeled in the G-rich and C-rich strands. Two bands ([Figure 5](#F5){ref-type="fig"}B, bands 1 and 2) were observed in both duplex DNA samples (lanes 2 and 3) pre-incubated with 100 mM KCl. These bands were duplex DNA species, since they both migrated differently to the single-stranded intramolecular G-quadruplex species. The duplex DNA species containing the partially unwound region was less compact than the linear duplex DNA and as expected showed slower migration in EMSA. Thus band 1 corresponds to the duplex DNA species containing the G-quadruplex structure, while band 2 corresponds to the fully linear duplex DNA. By coincidence, this band migrates at the same point as the presumed dimer intermolecular species from the Pu60-mer. However, it cannot correspond to this species since the NHE 60 bp duplex DNA labeled on the C-rich strand also gives this species. Bands 1 and 2 were both extracted and subjected to DMS footprinting. The full DMS cleavage pattern of band 2 confirmed that it was a linear duplex DNA ([Figure 5](#F5){ref-type="fig"}C, lanes 3 and 4). A distinct DMS protection pattern among three runs of guanines (G3--G11, G16--G19 and G22--G25) was observed for the G-rich strand of band 1 ([Figure 5](#F5){ref-type="fig"}C, lanes 1 and 2). Although it is not quite as well defined as the DMS footprinting patterns of the G-quadruplex species obtained from single-stranded DNA (see [Figure 4](#F4){ref-type="fig"}B, lanes 1 and 2), the DMS footprinting pattern of band 1 corresponds very closely to that of the single-stranded species associated with the 5′-end product seen in the *Taq* polymerase stop assay.

Mutation of guanines in the loops leads to dramatic destabilization of the PDGF-A G-quadruplexes
------------------------------------------------------------------------------------------------

A full mutational analysis of the three consecutive 5′-runs of guanines provided further insight into the sequence requirements for stability of the NHE~PDGF-A~ G-quadruplexes. In accordance with the DMS footprinting studies on the predicted mixture of loop isomers (see Discussion Section), 12 sets of mutants, in which the individual loop isomers were selected for, were compared by the relative intensity of the CD at 285 nM (data not shown). In all cases, the mutant sequences that were predicted to form defined loop isomers showed lower stability. Surprisingly, all these guanine mutant isomers showed a significant decrease in parallel G-quadruplex signals and an increase in antiparallel signals. This shows that these mutants predominantly form antiparallel or hybrid parallel/antiparallel G-quadruplex structures, which is different from the biologically relevant NHE~PDGF-A~ G-quadruplex. Among these guanine mutant isomers, the most surprising results originated from two dual mutants, PA-Mut1 and PA-Mut2 ([Figure 6](#F6){ref-type="fig"}A). These two mutant oligomers were designed to provide dual G-to-T or G-to-A base mutations at G15 and G21 in the core sequence of NHE~PDGF-A~. PA-Mut1 and PA-Mut2 were chosen because of the identified cleavage sites shown in the DMS footprinting of the PDGF-A Pu48 and the 60 bp duplex of NHE~PDGF-A~ ([Figures 4](#F4){ref-type="fig"}B and [5](#F5){ref-type="fig"}C). Therefore, G15 and G21 are not required for G-tetrad formation, and it was predicted that a mutation at these positions would not affect the stability or folding of the G-quadruplex in the NHE~PDGF-A~. Unexpectedly, PA-Mut1 and PA-Mut2 both showed a significant decrease in ellipticity at 212 and 266 nm and an increase in the antiparallel shoulder absorption between 280 and 300 nm, compared with the wild-type sequence of the three consecutive 5′-runs of guanines of NHE~PDGF-A~ (PA-5W) ([Figure 6](#F6){ref-type="fig"}B). Substitution of other loop-position guanines with other bases also resulted in the same changes in CD. Figure 6.Sequences (**A**) and comparative CD spectra (**B**) of the wild-type sequence of the three 5′-end runs of guanines and the G15/G21 double mutation sequences in the presence of 100 mM KCl. Black line = wild-type sequence PA-5W, red line = double G-to-T mutation sequence PA-Mut1 and blue line = double G-to-A mutation sequence PA-Mut2. All CD data were obtained with a 5 μM strand concentration at 25°C.

Stabilization of the G-quadruplexes in the NHE~PDGF-A~ with small molecules
---------------------------------------------------------------------------

One important goal of our studies is to identify small molecules with the ability to specifically modulate PDGF-A gene expression through stabilization or modification of the biologically relevant G-quadruplex structures in the NHE~PDGF-A~. To gain further insight into the selective action of G-quadruplex-interactive agents with the NHE~PDGF-A~ sequence, three well-established G-quadruplex-interactive agents, TMPyP4, telomestatin and Se2SAP ([Figure 7](#F7){ref-type="fig"}A), were evaluated by a *Taq* polymerase stop assay with a DNA template containing the whole core sequence of the G-rich strand of NHE~PDGF-A~. TMPyP2 ([Figure 7](#F7){ref-type="fig"}A), a positional isomer of TMPyP4 that lacks the ability to insert or stack into the G-tetrad structures ([@B52]), served as the negative control compound in our studies. Since there was a considerable amount of 5′-end stop products formed in the absence of drugs and KCl ([Figure 7](#F7){ref-type="fig"}B, lane 2), we used an elevated primer extension temperature (60°C) to partially destabilize the arresting G-quadruplex structure and thereby permit a larger window for drug stabilization of the G-quadruplex structures. The pausing at the 5′-end stop product in the absence of G-quadruplex-interactive ligands and KCl at a high temperature of 60°C is another indication that the G-quadruplex structure in the 5′-end product is more stable than other possible G-quadruplex structures formed by the G-rich strand of NHE~PDGF-A~ ([Figure 7](#F7){ref-type="fig"}B, lane 2). This suggests that the 5′-end G-quadruplex is the primary G-quadruplex structure formed in NHE~PDGF-A~, corresponding to the one formed in the NHE duplex DNA. Figure 7.(**A**) Structures of the G-quadruplex-interactive compounds TMPyP4, telomestatin and Se2SAP, and the control compound TMPyP2. (**B**) The *Taq* polymerase stop assay was used to compare the stabilization of the NHE~PDGF-A~ G-quadruplex by TMPyP2 (lanes 3--7), TMPyP4 (lanes 8--12), telomestatin (lanes 13--17) and Se2SAP (lanes 18--22) by using increasing concentrations of drugs (0.01, 0.05, 0.5, 1 and 2.5 μM) at 60°C. Lane 1 is control, and lane 2 is without drug. (**C**) The ratios of the major arrest products of each sample to the total product were plotted against drug concentrations.

The results in [Figure 7](#F7){ref-type="fig"}B (lanes 3--7) and [Figure 7](#F7){ref-type="fig"}C (a) show that TMPyP2 had a negligible effect on the formation of polymerase stop arrest products. When the concentration of drugs was 0.05 μM and lower ([Figure 7](#F7){ref-type="fig"}B, lanes 8 and 9), TMPyP4 significantly increased stabilization of the 5′-end stop products in a concentration-dependent manner, but telomestatin and Se2SAP only marginally increased the formation of 5′-end stop products (lanes 13, 14, 19 and 20 in [Figure 7](#F7){ref-type="fig"}B). In contrast, when the concentration of all three drugs was 0.5 μM and higher, decreased formation of the 5′-end stop products was observed for all three G-quadruplex-interactive drugs, because of the accumulation of the 3′-end stop product. TMPyP4 achieved the maximum stabilizing effect on the 5′-end stop products at a concentration of 0.05 μM \[[Figure 7](#F7){ref-type="fig"}B, lane 9, and C (b)\]. The *Taq* polymerase stop assay also showed that these three G-quadruplex-interactive drugs induced formation of the 3′-end stop products at high drug concentrations (≥0.5 μM). A concentration-dependent increase in stabilization of the 3′-end stop products was also observed for all three drugs. However, telomestatin and Se2SAP were more selective at stabilizing the 3′-end stop product; both achieved the best stabilizing effect on the 3′-end G-quadruplex at a concentration of 1 μM \[[Figure 7](#F7){ref-type="fig"}B, lane 21, and C (c and d)\]. In addition, at drug concentrations of 1 and 2.5 μM, TMPyP4 exhibited preferential binding for duplex DNA over the G-quadruplex structures (lanes 11 and 12 in [Figure 7](#F7){ref-type="fig"}B).

TMPyP4 selectively inhibits the promoter activity of the NHE~PDGF-A~
--------------------------------------------------------------------

In light of our results demonstrating that the duplex DNA of NHE~PDGF-A~ can form a G-quadruplex structure, we sought to determine if stabilization of this G-quadruplex structure affects *PDGF-A* transcription *in vivo*. Therefore, we constructed pGL3-Basic derivative (pA361) in which the human genomic DNA fragment containing the proximal promoter region of *PDGF-A* (--218 to +142, relative to the transcriptional start site) was inserted upstream of the firefly luciferase reporter gene. When transfected into MIA PaCa-2 human pancreatic cancer cells, pA361 drove luciferase expression into these cells. Thus, the *PDGF-A* proximal promoter, which contains the complete NHE~PDGF-A~ core sequence, can drive transcription *in vivo*. Furthermore, RT-PCR studies demonstrated significantly higher PDGF-A expression in MIA PaCa-2 cells than in the normal pancreatic cell line HPDE-6 (data not shown).

Since TMPyP4 at low concentrations selectively stabilized the biologically relevant G-quadruplex structure (the 5′-end stop product) formed by duplex NHE~PDGF-A~ DNA *in vitro*, we directly assessed its specific biological effects on *PDGF-A* transcription. MIA PaCa-2 cells were co-transfected with plasmids pA361 and pRL-TK as an internal control and treated with varying concentrations of TMPyP4 or TMPyP2. We measured the expression of firefly luciferase relative to the renilla luciferase of pRL-TK by dual luciferase assay, 24 h after transfection. At all concentrations used, TMPyP4 reduced the expression of firefly luciferase activity by inhibiting the promoter activity of NHE~PDGF-A~, whereas TMPyP2 had no significant effect on the firefly luciferase activity ([Figure 8](#F8){ref-type="fig"}). We found that 10 μM TMPyP4 could reduce the expression of firefly luciferase to ∼50% of the control, indicating that the stabilization of the G-quadruplex has a strong repression effect on promoter activity of NHE~PDGF-A~. This data suggests that the stable G-quadruplex structure formed locally in the human *PDGF-A* promoter at NHE is likely to behave as a transcription repression *in vivo*. Figure 8.Dual luciferase assay to determine the effect of TMPyP4 and TMPyP2 on the transcriptional activity of PDGF-A basal promoter containing the NHE. The comparative firefly luciferase expressions (firefly/renilla) of TMPyP2 and TMPyP4 are shown in the histograms. The values are the average of three independent experiments. Error bars are ± SE.

DISCUSSION
==========

Up-regulation of PDGF activity has been implicated in the pathogenesis of a number of serious diseases, including cancer, as well as other disorders characterized by excessive cell growth, such as atherosclerosis and various fibrotic conditions ([@B3],[@B5],[@B6]), as described in the Introduction Section. One strategy to block PDGF signaling pathways is to target the PDGF receptors. Employment of this strategy led to the discovery of selective PDGF antagonists ([@B5],[@B53],[@B54]). For example, the PDGF receptor kinase inhibitor STI-571 (Gleevec) has been approved for clinical use for the treatment of certain tumors ([@B54; @B55; @B56]). Because the PDGF-A polypeptide is short in length, it has not been thought of as a druggable anticancer target. However, another viable strategy for targeting PDGF signaling pathways in tumors is to decrease *PDGF-A* expression by inhibiting its promoter activity. Transcription of *PDGF-A* is under the strict control of NHE~PDGF-A~ in the promoter. The unwound paranemic NHE~PDGF-A~ structure plays an important role in regulating transcription factors that bind to the *PDGF-A* promoter. The G-rich strand of NHE~PDGF-A~, which contains five G-tracts with each G-tract separated from the neighboring G-tract by a single intervening base, is anticipated to form G-quadruplex structures under physiological conditions. Therefore, the NHE~PDGF-A~ G-quadruplex structure is potentially involved in transcriptional control of PDGF-A expression, perhaps as the silencer element. Consequently, the search for compounds that have selectivity for binding to the NHE~PDGF-A~ G-quadruplex and that inhibit *PDGF-A* gene expression might well be valuable in the treatment of some cancers and other disorders, as described earlier.

In the present study, we demonstrate that the G-rich strand of NHE~PDGF-A~, located within the proximal promoter region of *PDGF-A*, is able to form two stable intramolecular parallel G-quadruplex structures (3′-end and 5′-end G-quadruplexes) that are potentially involved in transcriptional regulation. The formation of these G-quadruplex structures is K^+^-dependent. The DMS footprinting patterns of the G-quadruplexes formed by PDGF-A Pu48 and Pu60 imply that these structures must contain at least four G-tetrads, and this is supported by the CD data in [Figure 2](#F2){ref-type="fig"}A, in which the molar ellipticity is greater for the PDGF-A G-quadruplex than for the c-Myc G-quadruplex. Significantly, an intramolecular G-quadruplex that has a similar folding pattern to the 5′-end G-quadruplex found in single-stranded DNA of NHE~PDGF-A~ can be formed within the duplex DNA of NHE~PDGF-A~. In light of the protocol for formation of the duplex containing the G-quadruplex, the G-quadruplex obtained within the duplex DNA of NHE~PDGF-A~ probably forms prior to the formation of the duplex species. Thus, the species formed during the annealing is a result of hybridization of the single-stranded G-rich strand already containing the G-quadruplex with the single-stranded C-rich strand. This is unlikely to be the same mechanism for the formation of the G-quadruplex structure within the duplex DNA in *in vivo* situations where superhelicity is involved (see subsequently). Nevertheless, this is the first time that we have been able to isolate the duplex DNA containing a G-quadruplex structure *in vitro*. This unique structure is likely to represent the dominant biologically relevant G-quadruplex structure formed in the PDGF-A promoter. It has been proposed that superhelicity of genomic DNA may play an important role in determining the presence of such an interconversion ([@B57],[@B58]). The functional analysis of the *PDGF-A* promoter revealed that the NHE~PDGF-A~ adopted a non-B-DNA conformation and was hypersensitive to the S1 nuclease in the supercoiled plasmids ([@B13; @B14; @B15; @B16]). This provides further evidence that the formation of a G-quadruplex in the NHE~PDGF-A~ can compete with the superhelical duplex conformation *in vivo*. The implication of the formation of a stable G-quadruplex in duplex DNA is that the C-rich strand forms a single-stranded DNA loop, which may be in equilibrium with an i-motif structure.

The folding pattern of the biologically relevant G-quadruplex structure formed by the three consecutive G-tracts (G1--G25) at the 5′-end of NHE~PDGF-A~ duplex DNA most likely represents a mixture of different loop isomers. Of particular interest, the 13-mer G-tract (G1--G13) must provide the two runs of guanines at the 5′-end. The flanking regions of NHE~PDGF-A~ are also made up of polypurine and polypyrimidine elements, which may have a significant impact on the propensity to form the G-quadruplex in the G-rich strand of NHE~PDGF-A~ double-stranded DNA. The overall folding patterns of the parallel G-quadruplex structure in NHE~PDGF-A~ duplex DNA has been defined by its characteristic CD spectra, which demonstrates that it has a unique double-chain reversal structure. Previously, examples of G-quadruplexes consisting of double-chain reversals in promoter regions have been confined to three tetrads with a single base in the internal loop. This is the first example of a G-quadruplex with four tetrads and a two-base internal loop. The DMS footprinting pattern of the G-quadruplex in NHE~PDGF-A~ duplex DNA reveals that the 3′-face of this G-quadruplex structure has two runs of four guanines, which are separated by a two-base (CG) internal loop. A molecular model of the four G-tetrads in the NHE~PDGF-A~ G-quadruplex structure shows that a two-base internal loop is the minimum required to bridge two runs of four guanines ([Figure 9](#F9){ref-type="fig"}A). The opposite 5′-face of this G-quadruplex structure is constructed from the run of 13 contiguous guanines, in which the DMS footprinting pattern predicts a mixture of at least four double-chain reversal loop isomers ([Figure 9](#F9){ref-type="fig"}B). Loop isomers 'a', 'b', and 'c' in [Figure 9](#F9){ref-type="fig"}B have a two-base internal loop on the 5′-face dictated by the demonstrated DMS cleavages of G11, G12 and G13 ('a' isomer), G12 and G13 ('b' isomer) and G1 and G2 ('c' isomer) in the core sequence of NHE~PDGF-A~ (see [Figure 4](#F4){ref-type="fig"}B). Finally, the cleavage of G5, G6 and G7 predicts loop isomer 'd'. By analogy with the c-Myc parallel G-quadruplex structure, in which the double-chain reversal loops on the opposite face are sufficient to stabilize a third intervening loop size of six bases, the double-chain reversals in the NHE~PDGF-A~ G-quadruplex can stabilize a third internal loop of up to five bases (as predicted in loop isomer 'a' in [Figure 9](#F9){ref-type="fig"}B) ([@B38]). Two views of a molecular model of loop isomer 'a' having the predicted folding pattern are shown in [Figure 9](#F9){ref-type="fig"}A. Figure 9.(**A**) Model of the biologically relevant NHE~PDGF-A~ G-quadruplex \[loop isomer 5′-([@B2],[@B5],[@B2])-3′\], which contains two 2-base double-chain reversal loops and one 5-base intervening loop (guanines = red, cytosines = yellow and K^+^ ions = white). For clarity, hydrogen atoms have been removed. In the left panel, the two 2-base double-chain reversal loops are shown on each side of model, and in the right panel, the model has been rotated to show the 5-base intervening loop on the right side of model. (**B**) Proposed folding patterns of the four different loop isomers formed in the core sequence of NHE~PDGF-A~. Guanines = red, cytosines = yellow.

A surprising finding illustrated by the CD results shown in [Figure 6](#F6){ref-type="fig"}B for two dual mutant oligomers is that base changes, even in potential loop positions, result in destabilization and apparent dramatic changes in the folding patterns. This is in contrast to the c-Myc G-quadruplex, where elimination of the redundancy in loop isomers by judicial G-to-T mutations does not dramatically change the stability or folding patterns of the parallel-stranded G-quadruplex ([@B38]). The effects of G-to-N mutations in the NHE~PDGF-A~ G-quadruplexes are not limited to the run of 13 contiguous guanines, but also occur when the 3′ terminal guanines in the two runs of 5 guanines (G15 and G21) are mutated to thymines or adenines. On the basis of DMS cleavage results, these guanines are predicted to be predominantly in the loops, implying that the dynamic equilibrium between different loop isomers is an important feature of both stability and formation of the parallel-stranded species. This phenomenon may be uniquely linked to the 13 contiguous guanines in this promoter sequence.

An important aim of our research program is to identify small molecules that can selectively modulate *PDGF-A* transcription by stabilizing or modifying the unique G-quadruplex structures formed by NHE~PDGF-A~. Therefore, we examined the affinities of three well-known G-quadruplex-interactive drugs (TMPyP4, Se2SAP and telomestatin) for the NHE~PDGF-A~ G-quadruplex. The results of our *Taq* polymerase stop assays revealed that these three drugs preferentially interact with and stabilize the 5′-end NHE~PDGF-A~ G-quadruplex, which has a similar folding pattern to the biological G-quadruplexes formed in the NHE~PDGF-A~ duplex DNA at low concentrations. TMPyP4 exhibited stronger selectivity than either Se2SAP or telomestatin for stabilization of the 5′-end stop product. Thus, TMPyP4 appeared to be an ideal candidate for modulating *PDGF-A* transcription. Our data confirms that, in cells, TMPyP4 can specifically downregulate *PDGF-A* promoter activity by interacting with the NHE~PDGF-A~ G-quadruplex. Because TMPyP4, and not TMPyP2, inhibits *PDGF-A* proximal promoter activity, this is strong evidence that G-quadruplexes exist *in vivo* and that NHE~PDGF-A~ G-quadruplex structures act as transcriptional silencers for *PDGF-A*.

Finally, the relationship of the 5′SHS and intron SHS elements to the dynamic equilibrium of the G-quadruplex and associated C-strand structures remains to be determined. The complementarity of the 5′SHS and the 5′-end of the intron SHS is suggestive of the interaction of these elements. Experiments addressing this question are in progress.
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